October 1989
Volume 30, Issue 10
Free
Articles  |   October 1989
The intravitreal penetration of ceftriaxone in man following systemic administration.
Author Affiliations
  • M Sharir
    Infectious Diseases Unit, Chaim Sheba Medical Center, Tel-Aviv University School of Medicine, Tel-Hashomer, Israel.
  • G Triester
    Infectious Diseases Unit, Chaim Sheba Medical Center, Tel-Aviv University School of Medicine, Tel-Hashomer, Israel.
  • J Kneer
    Infectious Diseases Unit, Chaim Sheba Medical Center, Tel-Aviv University School of Medicine, Tel-Hashomer, Israel.
  • E Rubinstein
    Infectious Diseases Unit, Chaim Sheba Medical Center, Tel-Aviv University School of Medicine, Tel-Hashomer, Israel.
Investigative Ophthalmology & Visual Science October 1989, Vol.30, 2179-2183. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Sharir, G Triester, J Kneer, E Rubinstein; The intravitreal penetration of ceftriaxone in man following systemic administration.. Invest. Ophthalmol. Vis. Sci. 1989;30(10):2179-2183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Seventeen patients who underwent vitreal surgery received ceftriaxone (Rocephin) 1-2 g intramuscularly at various time intervals before surgery. Specimens of serum and vitreous were assayed for ceftriaxone concentrations both by bioassay and high pressure liquid chromatography. All patients had detectable vitreous (and serum) ceftriaxone concentrations at all time periods. Vitreous ceftriaxone levels at the first 4.5 hr following the administration of the antibiotic ranged from 1.4-19.4 micrograms/ml and averaged 5.9 micrograms/ml. At 12-13 hr following ceftriaxone administration vitreous concentrations were 11.5 (+/- 9.0) micrograms/ml. Ceftriaxone in intramuscular administration could be used as prophylaxis against ceftriaxone-susceptible microorganisms in vitreal surgery. Ceftriaxone is the first antibiotic for which reliable penetration into the vitreous is demonstrable following intramuscular administration.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×